Towards a targeted, risk-based, antifungal strategy in neutropenic patients

Br J Haematol. 2000 Aug;110(2):273-84. doi: 10.1046/j.1365-2141.2000.02014.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Bacteremia / complications
  • Bone Marrow Transplantation
  • Glucocorticoids / adverse effects
  • Graft vs Host Disease / complications
  • Humans
  • Mycoses / etiology
  • Mycoses / prevention & control*
  • Neutropenia / etiology*
  • Opportunistic Infections / prevention & control
  • Patient Selection*
  • Risk Factors
  • Severity of Illness Index

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Glucocorticoids